BCL10 mediates lipopolysaccharide/Toll-like receptor-4 signaling through interaction with Pellino2

被引:41
作者
Liu, YL [1 ]
Dong, W [1 ]
Chen, L [1 ]
Xiang, R [1 ]
Xiao, HZ [1 ]
De, GJ [1 ]
Wang, ZM [1 ]
Qi, YP [1 ]
机构
[1] Wuhan Univ, Coll Life Sci, Dept Biotechnol, Key Lab Minist Educ, Wuhan 430072, Peoples R China
关键词
D O I
10.1074/jbc.M400241200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Toll-like receptor (TLR) pathways signal through microbial components stimulation to induce innate immune responses. Herein, we demonstrate that BCL10, a critical molecule that signals between the T cell receptor and IkappaB kinase complexes, is involved in the innate immune system and is required for appropriate TLR4 pathway and nuclear factor-kappaB (NF-kappaB) activation. In response to lipopolysaccharide (LPS) stimulation, BCL10 was recruited to TLR4 signaling complexes and associated with Pellino2, an essential component downstream of BCL10 in the TLR4 pathway. In a BCL10-deficient macrophage cell line, LPS-induced NF-kappaB activation was consistently defective, whereas activator protein-1 and Elk-1 signaling was intact. In addition, we found that BCL10 was targeted by SOCS3 for negative regulation in LPS signaling. The recruitment of BCL10 to TLR4 signaling complexes was attenuated by induced expression of SOCS3 in a feedback loop. Furthermore, ectopic SOCS3 expression blocked the interaction between BCL10 and Pellino2 together with BCL10-generated NF-kappaB activation and inducible nitric-oxide synthase expression. Together, these data define an important role of BCL10 in the innate immune system.
引用
收藏
页码:37436 / 37444
页数:9
相关论文
共 33 条
[1]   Toll-like receptor signaling [J].
Akira, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (40) :38105-38108
[2]   Toll-like receptor signaling pathways [J].
Barton, GM ;
Medzhitov, R .
SCIENCE, 2003, 300 (5625) :1524-1525
[3]   Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation [J].
Berlato, C ;
Cassatella, MA ;
Kinjyo, I ;
Gatto, L ;
Yoshimura, A ;
Bazzoni, F .
JOURNAL OF IMMUNOLOGY, 2002, 168 (12) :6404-6411
[4]   CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-κB [J].
Bertin, J ;
Wang, L ;
Guo, Y ;
Jacobson, MD ;
Poyet, JL ;
Srinivasula, SM ;
Merriam, S ;
DiStefano, PS ;
Alnemri, ES .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (15) :11877-11882
[5]  
Cavalli F, 2001, Hematology Am Soc Hematol Educ Program, P241
[6]   Involvement of receptor-interacting protein 2 in innate and adaptive immune responses [J].
Chin, AI ;
Dempsey, PW ;
Bruhn, K ;
Miller, JF ;
Xu, Y ;
Cheng, GH .
NATURE, 2002, 416 (6877) :190-194
[7]   Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs [J].
Dalpke, AH ;
Opper, S ;
Zimmermann, S ;
Heeg, K .
JOURNAL OF IMMUNOLOGY, 2001, 166 (12) :7082-7089
[8]   A new protein containing an SH2 domain that inhibits JAK kinases [J].
Endo, TA ;
Masuhara, M ;
Yokouchi, M ;
Suzuki, R ;
Sakamoto, H ;
Mitsui, K ;
Matsumoto, A ;
Tanimura, S ;
Ohtsubo, M ;
Misawa, H ;
Miyazaki, T ;
Leonor, N ;
Taniguchi, T ;
Fujita, T ;
Kanakura, Y ;
Komiya, S ;
Yoshimura, A .
NATURE, 1997, 387 (6636) :921-924
[9]  
ICHIKO K, 2002, IMMUNITY, V17, P583
[10]   Pellino2 activates the mitogen activated protein kinase pathway [J].
Jensen, LE ;
Whitehead, AS .
FEBS LETTERS, 2003, 545 (2-3) :199-202